Drug Shortage Report for APO-TADALAFIL

Last updated on 2019-04-26 History
Report ID 79051
Drug Identification Number 02422107
Brand name APO-TADALAFIL
Common or Proper name TADALAFIL
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4 BLS
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-03-18
Estimated end date 2019-04-26
Actual end date 2019-04-25
Shortage status Resolved
Updated date 2019-04-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-04-26 French Compare
v7 2019-04-26 English Compare
v6 2019-04-22 French Compare
v5 2019-04-22 English Compare
v4 2019-04-08 French Compare
v3 2019-04-08 English Compare
v2 2019-03-20 French Compare
v1 2019-03-20 English Compare

Showing 1 to 8 of 8